Reuters Events: Pharma 2022 is where patient experts, leading solution providers, and pharma changemakers commit to business transformation as the catalyst for maximum patient impact.
Du mardi 11 octobre 2022 au jeudi 13 octobre 2022
Nice - ile de france
Comprehensive frameworks for equitable access and accelerated digital transformations are soon to be realized. But progress is slowing, risking a return to the old model plagued by persistent health disparities.
To thrive, each strategy and tactic must be centred with a whole-human approach, ensuring an agile, patient-driven, technology-enabled change.
You must advance intelligent automation, delivering value-driven content that enhance patient and HCP experiences, activate new skillsets for field teams to strengthen clinical practices, whilst collaborating with stakeholders – and competitors – to drastically improve equitable access to the vast galaxy of innovation improving patient outcomes and propelling commercial growth.
Reuters Events: Pharma 2022 (11-13 October, Nice France - formerly eyeforpharma Barcelona) is the only place where patient experts, leading solution providers, and pharma changemakers – from commercial, marketing, medical affairs, patient engagement, market access and RWE - commit to business transformation as the catalyst for maximum patient impact.
Our 2022 industry defining themes:
- New Products, New Models: Advance hybrid-launch strategies, RWE-standards, and value-communication to deliver on stakeholder needs and drive portfolio performance
- Purposeful Leadership: Utilise transparency and integrity to boost cross-functional alignment around one strategy. Combine deep clinical and business expertise to maximise ROI and patient outcomes
- Humanize Digital: Harmonize data, deploy human-centred AI and develop insights to generate an upgraded customer experience with value-driven content. Go beyond the pill to facilitate adherence
- Equity Unrestrained: Remove health disparities, set a pan-EU standard for innovation and intensify collaboration to speed up timeframes from authorisation to access